cmv-dcs
Vaccineexperimental
Clinical trial activity
2 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2008 (NCT00693095)
Timeline
Indications
Studied for
Mechanism of action
- CytomegalovirusImmunity, active
Cytomegalovirus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- cmv-dcs
- human cmv pp65-lamp mrna-pulsed autologous dcs
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02366728 | Phase 2 | Sep 1, 2015 | Duke University |
| NCT00693095 | Phase 1 | Sep 1, 2008 | Duke University |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Duke University | Academic/Hospital | 2 | 2 | 2 | 2008 |
1 organizations
Page 1 / 1